China has now surpassed the US for the number of clinical trials per year, and they're 50-100% faster there, too. U.S. and other Western pharmaceutical firms increasingly license innovative drugs from China; In 2025, deals valued from China accounted for about one-third of big pharma licensing agreements.
The U.S. biotech ecosystem has long been driven by NIH-backed R&D, but that has recently been radically cut. Will this be another case where Trump delivers a win for China? Destroying something at home for right-wing ideological reasons, just to let China swoop in to collect the prize. In this case becoming number 1 in global pharmaceuticals?
Outside America, the rest of the world is a winner here. Chinese industrialisation is driving global deflation and cheaper goods in transport, energy, and computing. It will be great if we can add biotech and pharmaceuticals to that list.
China’s Biotech Is Cheaper and Faster
Westoid Corpo's take all that state aid and then waste it on share buy backs while chinaman is out competing them on quality and price
The normie sees nothing wrong with this set up 🤡